Spring has sprung with the announcement of a king-size deal: Danaher's $21.4 billion cash acquisition of GE Life Sciences, known as GE Biopharma, from General Electric Company (GE). Here's a quick … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
March 27, 2019
DIAGNOSTIC DEALS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
March 25, 2019
The past few weeks have brought snow to parts of the country that don't usually see the white stuff, and a flurry of diagnostic deals. Although some pundits continue to speculate about a business … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
January 30, 2019
A government shutdown, ongoing tensions with China and concerns about continued economic growth have marked the beginning of 2019. Against this backdrop, diagnostic deals continue to move forward. … [Read more...]
PRECISION MEDICINE
Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle
January 21, 2019
The Theranos debacle hasn't dissuaded retailers from partnering with labs. LabCorp & Walgreens Walgreens, Theranos's ex-retail partner, has moved on and entered into an agreement with another … [Read more...]
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
January 15, 2019
While overall deal volume for 2018 increased, the year was relatively light in the dramatic transactions that were so prolific in the previous two years. Here's a quick overview of deals and … [Read more...]
DISTRIBUTION AGREEMENTS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
December 17, 2018
As the year winds down, diagnostic deals aren't as plentiful. Nevertheless, there have been some significant transactions. Here's a recap of the key activity from mid-October through the third week of … [Read more...]
PARTNERSHIPS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
November 12, 2018
The swirl of autumn leaves has brought a swirl of diagnostic deals. Here's a recap of the key activity from mid-September through the third week of October. M&A and Asset Sales Quest Diagnostics … [Read more...]
ACQUISITIONS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
October 15, 2018
Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from mid-August through the third week of September. M&A and Asset Sales This … [Read more...]
DISTRIBUTION AGREEMENTS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
August 31, 2018
Forget the lazy days of summer–lab companies have been moving forward with deals. Here's a look at key activity from mid-July through the third week of August. M&A Roche acquired an additional … [Read more...]
MERGERS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
July 30, 2018
After last month’s flurry of transactions, business calmed down as it often does during the start of summer. Here are the key deals and trends from mid-June through the third week of … [Read more...]
